Hangzhou Tigermed Consulting Dividends and Buybacks
Dividend criteria checks 4/6
Hangzhou Tigermed Consulting is a dividend paying company with a current yield of 0.93% that is well covered by earnings.
Key information
0.9%
Dividend yield
-0.4%
Buyback Yield
| Total Shareholder Yield | 0.6% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 10.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.0784 |
| Payout ratio | 51% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: HNGZ.Y's dividends per share have been stable in the past 10 years.
Growing Dividend: HNGZ.Y's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Hangzhou Tigermed Consulting Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HNGZ.Y) | 0.9% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Life Sciences) | 0.5% |
| Analyst forecast (HNGZ.Y) (up to 3 years) | 0.9% |
Notable Dividend: HNGZ.Y's dividend (0.93%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.37%).
High Dividend: HNGZ.Y's dividend (0.93%) is low compared to the top 25% of dividend payers in the US market (4.26%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (51.2%), HNGZ.Y's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (72.2%), HNGZ.Y's dividend payments are covered by cash flows.